Biomedical Research Laboratori

Basic Information

7899 Mastin
Overland Park, KS, 66204

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. ANTI-IDIOTYPIC MONOCLONAL ANTIBODY (AIMA) THERAPY HAS CURATIVE POTENTIAL FOR LOW-GRADE B-CELL LYMPHOMAS THROUGH IMMUNOLOGIC DOWN REGULATION OF THE MALIGNANT IDIOTYPIC CLONE AS WELL AS ANTIBODY-DEPENDENT CELL MEDIATED CYTOTOXICITY.

    Amount: $48,249.00

    ANTI-IDIOTYPIC MONOCLONAL ANTIBODY (AIMA) THERAPY HAS CURATIVE POTENTIAL FOR LOW-GRADE B-CELL LYMPHOMAS THROUGH IMMUNOLOGIC DOWN REGULATION OF THE MALIGNANT IDIOTYPIC CLONE AS WELL AS ANTIBODY-DEPENDE ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. SYNTHESIS OF IMAGABLE IODINATED ESTRADIOL- PHASE I

    Amount: $269,150.00

    THE HIGH INCIDENCE OF BREAST CANCER IN WOMEN MAKES THIS DISEASE THE LEADING CANCER TYPE IN THIS POPULATION. THE PROPER STAGING OF THIS CANCER AND THE DETERMINATION OF THE PRESENCE OR ABSENCE OF ESTROG ...

    SBIR Phase II 1984 Department of Health and Human Services
  3. SYNTHESIS OF IMAGABLE IODINATED ESTRADIOL- PHASE I

    Amount: $33,500.00

    N/A

    SBIR Phase I 1983 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government